Astrana Health (ASTH) Invested Capital (2011 - 2026)

Astrana Health (ASTH) has 16 years of Invested Capital data on file, last reported at $863.1 million in Q1 2026.

• Quarterly Invested Capital rose 13.12% year-over-year to $863.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $863.1 million (up 13.12% YoY) and the FY2025 annual result came in at $827.2 million, up 13.92% from the prior year.
• Invested Capital advanced to $863.1 million in Q1 2026 per ASTH's latest filing, from $827.2 million in the prior quarter.
• The five-year high for Invested Capital was $863.1 million in Q1 2026, with the low at $474.4 million in Q1 2022.
• Average Invested Capital over 5 years is $660.3 million, with a median of $659.6 million recorded in 2024.
• Year-over-year, Invested Capital soared 36.53% in 2022 and grew 12.0% in 2025.
• Astrana Health's Invested Capital stood at $550.2 million in 2022, then gained by 12.38% to $618.3 million in 2023, then grew by 17.43% to $726.1 million in 2024, then grew by 13.92% to $827.2 million in 2025, then climbed by 4.34% to $863.1 million in 2026.
• Business Quant data shows ASTH's Invested Capital at $863.1 million in Q1 2026, $827.2 million in Q4 2025, and $823.4 million in Q3 2025.